{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:32:30Z","timestamp":1772119950887,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Health Canada\u2019s Substance Use and Addictions Program (SUAP) Grant","award":["2122-HQ-000021"],"award-info":[{"award-number":["2122-HQ-000021"]}]},{"name":"Canadian Institutes of Health Research (CIHR) Grant","award":["181006"],"award-info":[{"award-number":["181006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Urban Health"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s11524-024-00846-y","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T13:01:43Z","timestamp":1711026103000},"page":"252-261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bridging the Gap in Harm Reduction Using Mobile Overdose Response Services (MORS) in the Context of the COVID-19 Pandemic: A Qualitative Study"],"prefix":"10.1007","volume":"101","author":[{"given":"Boogyung","family":"Seo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Rioux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Rider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Teare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Taplay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1566-0015","authenticated-orcid":false,"given":"S. Monty","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"key":"846_CR1","unstructured":"Health Canada. Opioid- and stimulant-related harms \u2014 Canada.ca. Published 2023. Accessed July 19, 2023. https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants\/"},{"issue":"2","key":"846_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5114\/ait.2020.94756","volume":"52","author":"K Ayoo","year":"2020","unstructured":"Ayoo K, Mikhaeil J, Huang A, W\u0105sowicz M. The opioid crisis in North America: facts and future lessons for Europe. Anaesthesiol Intensive Ther. 2020;52(2):139\u201347. https:\/\/doi.org\/10.5114\/ait.2020.94756.","journal-title":"Anaesthesiol Intensive Ther."},{"key":"846_CR3","unstructured":"BC Gov News. Provincial health officer declares public health emergency | BC Gov News. Published April 14, 2016. Accessed February 5, 2024. https:\/\/news.gov.bc.ca\/releases\/2016HLTH0026-000568"},{"issue":"5","key":"846_CR4","doi-asserted-by":"publisher","first-page":"e0229208","DOI":"10.1371\/journal.pone.0229208","volume":"15","author":"B Pauly","year":"2020","unstructured":"Pauly B, Wallace B, Pagan F, et al. Impact of overdose prevention sites during a public health emergency in Victoria. Canada PLoS One. 2020;15(5):e0229208. https:\/\/doi.org\/10.1371\/journal.pone.0229208.","journal-title":"Canada. PLoS One"},{"key":"846_CR5","unstructured":"Health Canada. Supervised consumption explained: types of sites and services. Published May 15, 2018. Accessed July 31, 2023. https:\/\/www.canada.ca\/en\/health-canada\/services\/substance-use\/supervised-consumption-sites\/explained.html"},{"key":"846_CR6","unstructured":"Canadian Centre on Substance Use and Addiction. The availability of take-home naloxone in Canada.; 2016. https:\/\/www.ccsa.ca\/sites\/default\/files\/2019-05\/CCSA-CCENDU-Take-Home-Naloxone-Canada-2016-en.pdf.\u00a0Accessed 12 Sept 2023."},{"issue":"1","key":"846_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13011-022-00494-y","volume":"17","author":"A Foreman-Mackey","year":"2022","unstructured":"Foreman-Mackey A, Pauly B, Ivsins A, Urbanoski K, Mansoor M, Bardwell G. Moving towards a continuum of safer supply options for people who use drugs: a qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada. Subst Abuse Treat Prev Policy. 2022;17(1):66. https:\/\/doi.org\/10.1186\/s13011-022-00494-y.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"2","key":"846_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s43678-021-00229-1","volume":"24","author":"SA Weicker","year":"2022","unstructured":"Weicker SA, Speed KA, Hyshka E, Mrochuk M, Kosteniuk B, Dong K. Emergency department care for patients who use opioids during the COVID-19 pandemic. Can J Emerg Med. 2022;24(2):123\u20135. https:\/\/doi.org\/10.1007\/s43678-021-00229-1.","journal-title":"Can J Emerg Med"},{"key":"846_CR9","doi-asserted-by":"publisher","first-page":"108374","DOI":"10.1016\/j.jsat.2021.108374","volume":"129","author":"C Russell","year":"2021","unstructured":"Russell C, Ali F, Nafeh F, Rehm J, LeBlanc S, Elton-Marshall T. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): a national qualitative study. J Subst Abuse Treat. 2021;129:108374. https:\/\/doi.org\/10.1016\/j.jsat.2021.108374.","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"846_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12954-022-00712-7","volume":"19","author":"R Cassie","year":"2022","unstructured":"Cassie R, Hayashi K, DeBeck K, et al. Difficulty accessing supervised consumption services during the COVID-19 pandemic among people who use drugs in Vancouver, Canada. Harm Reduct J. 2022;19(1):126. https:\/\/doi.org\/10.1186\/s12954-022-00712-7.","journal-title":"Harm Reduct J"},{"issue":"1","key":"846_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12954-022-00620-w","volume":"19","author":"N Minoyan","year":"2022","unstructured":"Minoyan N, H\u00f8j SB, Zolopa C, Vlad D, Bruneau J, Larney S. Self-reported impacts of the COVID-19 pandemic among people who use drugs: a rapid assessment study in Montreal, Canada. Harm Reduct J. 2022;19(1):38. https:\/\/doi.org\/10.1186\/s12954-022-00620-w.","journal-title":"Harm Reduct J"},{"key":"846_CR12","unstructured":"Canadian Centre on Substance Use and Addiction. Impacts of the COVID-19 Pandemic on Substance Use Treatment Capacity in Canada.\u00a0Published online 2020. https:\/\/www.ccsa.ca\/impacts-covid-19-pandemic-substance-use-treatment-capacity-canada. Accessed 12 Sept 2023."},{"key":"846_CR13","unstructured":"Alberta Health Services. Spike in opioid overdose calls prompts public warning. Alberta Health Services. Published 2019. https:\/\/www.albertahealthservices.ca\/news\/Page14902.aspx.\u00a0Accessed 3 Feb 2024."},{"key":"846_CR14","unstructured":"Vancouver Coastal Health. Overdose response, Naloxone & training | Vancouver Coastal Health. Accessed February 3, 2024. https:\/\/www.vch.ca\/en\/overdose-response-naloxone-training"},{"key":"846_CR15","unstructured":"Health Canada. Modelling opioid-related deaths during the overdose crisis. Published November 26, 2020. Accessed February 21, 2024. https:\/\/www.canada.ca\/en\/health-canada\/services\/opioids\/data-surveillance-research\/modelling.html"},{"key":"846_CR16","doi-asserted-by":"publisher","first-page":"103933","DOI":"10.1016\/j.drugpo.2022.103933","volume":"111","author":"C Russell","year":"2023","unstructured":"Russell C, Law J, Bonn M, Rehm J, Ali F. The increase in benzodiazepine-laced drugs and related risks in Canada: the urgent need for effective and sustainable solutions. Int J Drug Policy. 2023;111:103933. https:\/\/doi.org\/10.1016\/j.drugpo.2022.103933.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"846_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12954-021-00530-3","volume":"18","author":"M Perri","year":"2021","unstructured":"Perri M, Kaminski N, Bonn M, et al. A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone. Harm Reduct J. 2021;18(1):85. https:\/\/doi.org\/10.1186\/s12954-021-00530-3.","journal-title":"Harm Reduct J"},{"key":"846_CR18","unstructured":"NORS. National Overdose Response Service. NORS. https:\/\/www.nors.ca\/about. Accessed 10 Jan 2024."},{"key":"846_CR19","unstructured":"Brave. Brave Coop. https:\/\/brave.coop\/.\u00a0Accessed 17 Jan 2024."},{"key":"846_CR20","unstructured":"Never Use Alone. Never Use Alone \u2013 No Judgment, No Shaming, No Preaching, Just LOVE! https:\/\/neverusealone.com\/.\u00a0Accessed 13 Dec 2023."},{"key":"846_CR21","unstructured":"Lifeguard Digital Health Inc.\u00a0Lifeguard Digital Health. https:\/\/lifeguarddh.com\/.\u00a0Accessed 17 Jan 2024."},{"key":"846_CR22","unstructured":"Digital Overdose Response System. DORS. https:\/\/www.dorsapp.ca.\u00a0Accessed 17 Jan 2024."},{"issue":"20","key":"846_CR23","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191. https:\/\/doi.org\/10.1001\/jama.2013.281053.","journal-title":"JAMA"},{"key":"846_CR24","doi-asserted-by":"publisher","first-page":"103237","DOI":"10.1016\/j.drugpo.2021.103237","volume":"93","author":"F Ali","year":"2021","unstructured":"Ali F, Russell C, Nafeh F, Rehm J, LeBlanc S, Elton-Marshall T. Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: a national qualitative assessment in Canada. Int J Drug Policy. 2021;93:103237. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103237.","journal-title":"Int J Drug Policy"},{"issue":"13","key":"846_CR25","doi-asserted-by":"publisher","first-page":"7131","DOI":"10.3390\/ijerph18137131","volume":"18","author":"D Urrutia","year":"2021","unstructured":"Urrutia D, Manetti E, Williamson M, Lequy E. Overview of Canada\u2019s answer to the COVID-19 pandemic\u2019s first wave (January\u2013April 2020). Int J Environ Res Public Health. 2021;18(13):7131. https:\/\/doi.org\/10.3390\/ijerph18137131.","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"846_CR26","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s11524-022-00610-0","volume":"99","author":"R Ghose","year":"2022","unstructured":"Ghose R, Forati AM, Mantsch JR. Impact of the COVID-19 pandemic on opioid overdose deaths: a spatiotemporal analysis. J Urban Health. 2022;99(2):316\u201327. https:\/\/doi.org\/10.1007\/s11524-022-00610-0.","journal-title":"J Urban Health"},{"issue":"10","key":"846_CR27","doi-asserted-by":"publisher","first-page":"e0293251","DOI":"10.1371\/journal.pone.0293251","volume":"18","author":"A Butler","year":"2023","unstructured":"Butler A, Croxford R, McLeod KE, et al. The impact of COVID-19 on opioid toxicity deaths for people who experience incarceration compared to the general population in Ontario: a whole population data linkage study. PLoS One. 2023;18(10):e0293251. https:\/\/doi.org\/10.1371\/journal.pone.0293251.","journal-title":"PLoS One"},{"issue":"1","key":"846_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13722-020-00210-w","volume":"16","author":"E Cowan","year":"2021","unstructured":"Cowan E, Khan MR, Shastry S, Edelman EJ. Conceptualizing the effects of the COVID-19 pandemic on people with opioid use disorder: an application of the social ecological model. Addict Sci Clin Pract. 2021;16(1):4. https:\/\/doi.org\/10.1186\/s13722-020-00210-w.","journal-title":"Addict Sci Clin Pract"},{"key":"846_CR29","doi-asserted-by":"publisher","first-page":"103923","DOI":"10.1016\/j.drugpo.2022.103923","volume":"111","author":"KE Schneider","year":"2023","unstructured":"Schneider KE, Allen ST, Rouhani S, et al. Increased solitary drug use during COVID-19: an unintended consequence of social distancing. Int J Drug Policy. 2023;111:103923. https:\/\/doi.org\/10.1016\/j.drugpo.2022.103923.","journal-title":"Int J Drug Policy"},{"key":"846_CR30","unstructured":"Mental Health Commission of Canada. Mental health and substance use during COVID-19: spotlight on youth, older adults & stigma. Mental Health Commission of Canada. Published August 10, 2023. Accessed August 10, 2023. https:\/\/mentalhealthcommission.ca\/resource\/poll-covid-19-youth-older-adults-stigma\/"},{"issue":"4","key":"846_CR31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.34172\/ahj.2022.1274","volume":"14","author":"R Shankar","year":"2022","unstructured":"Shankar R, Bhattacharya V. Trends in substance use and abuse during COVID-19 among the general population. Addict Health. 2022;14(4):296\u2013308. https:\/\/doi.org\/10.34172\/ahj.2022.1274.","journal-title":"Addict Health."},{"issue":"3","key":"846_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.12927\/hcq.2022.26948","volume":"25","author":"L Husak","year":"2022","unstructured":"Husak L, Sovran V, Ytsma A, Comeau M. Impact of the COVID-19 pandemic on virtual care: a major shift for physicians and patients. Healthc Q. 2022;25(3):11\u20133. https:\/\/doi.org\/10.12927\/hcq.2022.26948.","journal-title":"Healthc Q."},{"key":"846_CR33","doi-asserted-by":"publisher","first-page":"205520762110284","DOI":"10.1177\/20552076211028404","volume":"7","author":"M Perri","year":"2021","unstructured":"Perri M, Guta A, Gagnon M, et al. Developing a digital health strategy for people who use drugs: lessons from COVID-19. Digit Health. 2021;7:205520762110284. https:\/\/doi.org\/10.1177\/20552076211028404.","journal-title":"Digit Health"},{"issue":"3","key":"846_CR34","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1080\/08897077.2019.1680479","volume":"42","author":"VWL Tsang","year":"2021","unstructured":"Tsang VWL, Papamihali K, Crabtree A, Buxton JA. Acceptability of technological solutions for overdose monitoring: perspectives of people who use drugs. Subst Abuse. 2021;42(3):284\u201393. https:\/\/doi.org\/10.1080\/08897077.2019.1680479.","journal-title":"Subst Abuse"},{"key":"846_CR35","doi-asserted-by":"publisher","first-page":"102245","DOI":"10.1016\/j.healthplace.2019.102245","volume":"61","author":"G Bardwell","year":"2020","unstructured":"Bardwell G, Strike C, Mitra S, et al. \u201cThat\u2019s a double-edged sword\u201d: exploring the integration of supervised consumption services within community health centres in Toronto. Canada Health Place. 2020;61:102245. https:\/\/doi.org\/10.1016\/j.healthplace.2019.102245.","journal-title":"Canada Health Place"},{"issue":"1","key":"846_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12954-020-00399-8","volume":"17","author":"B Muncan","year":"2020","unstructured":"Muncan B, Walters SM, Ezell J, Ompad DC. \u201cThey look at us like junkies\u201d: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduct J. 2020;17(1):53. https:\/\/doi.org\/10.1186\/s12954-020-00399-8.","journal-title":"Harm Reduct J"},{"key":"846_CR37","doi-asserted-by":"publisher","first-page":"100167","DOI":"10.1016\/j.dadr.2023.100167","volume":"7","author":"JM Bowles","year":"2023","unstructured":"Bowles JM, Kolla G, Smith LR, Scheim A, Dodd Z, Werb D. Disease-related stigma among people who inject drugs in Toronto amidst the COVID-19 pandemic. Drug Alcohol Depend Rep. 2023;7:100167. https:\/\/doi.org\/10.1016\/j.dadr.2023.100167.","journal-title":"Drug Alcohol Depend Rep"},{"key":"846_CR38","unstructured":"Public Health Agency of Canada. Government of Canada to remove COVID-19 border and travel measures effective October 1. Published September 25, 2022. Accessed August 21, 2023. https:\/\/www.canada.ca\/en\/public-health\/news\/2022\/09\/government-of-canada-to-remove-covid-19-border-and-travel-measures-effective-october-1.html"},{"issue":"9775","key":"846_CR39","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0140-6736(10)62353-7","volume":"377","author":"BD Marshall","year":"2011","unstructured":"Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T. Reduction in overdose mortality after the opening of North America\u2019s first medically supervised safer injecting facility: a retrospective population-based study. The Lancet. 2011;377(9775):1429\u201337. https:\/\/doi.org\/10.1016\/S0140-6736(10)62353-7.","journal-title":"The Lancet"},{"issue":"1","key":"846_CR40","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12889-017-4210-2","volume":"17","author":"RM Fernandes","year":"2017","unstructured":"Fernandes RM, Cary M, Duarte G, et al. Effectiveness of needle and syringe programmes in people who inject drugs \u2013 An overview of systematic reviews. BMC Public Health. 2017;17(1):309. https:\/\/doi.org\/10.1186\/s12889-017-4210-2.","journal-title":"BMC Public Health"},{"issue":"2","key":"846_CR41","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1016\/S2468-2667(23)00300-6","volume":"9","author":"I Rammohan","year":"2024","unstructured":"Rammohan I, Gaines T, Scheim A, Bayoumi A, Werb D. Overdose mortality incidence and supervised consumption services in Toronto, Canada: an ecological study and spatial analysis. Lancet Public Health. 2024;9(2):e79\u201387. https:\/\/doi.org\/10.1016\/S2468-2667(23)00300-6.","journal-title":"Lancet Public Health"},{"issue":"1","key":"846_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12954-018-0212-3","volume":"15","author":"C Strike","year":"2018","unstructured":"Strike C, Miskovic M. Scoping out the literature on mobile needle and syringe programs\u2014review of service delivery and client characteristics, operation, utilization, referrals, and impact. Harm Reduct J. 2018;15(1):6. https:\/\/doi.org\/10.1186\/s12954-018-0212-3.","journal-title":"Harm Reduct J"}],"container-title":["Journal of Urban Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11524-024-00846-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11524-024-00846-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11524-024-00846-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T16:36:16Z","timestamp":1714149376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11524-024-00846-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["846"],"URL":"https:\/\/doi.org\/10.1007\/s11524-024-00846-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3454672\/v1","asserted-by":"object"}]},"ISSN":["1099-3460","1468-2869"],"issn-type":[{"value":"1099-3460","type":"print"},{"value":"1468-2869","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"assertion":[{"value":"27 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted as part of a quality improvement project and received ethical approval from the University of Calgary Conjoint Health Research Ethics Board (REB21-1655).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}